...
机译:阿替利珠单抗联合贝伐珠单抗治疗韩国晚期肝细胞癌患者的疗效和安全性
Department of Hematology‐Oncology,Ulsan University Hospital;
Department of Oncology,University of Ulsan College of Medicine;
Department of Medicine,Samsung Medical CenterDivision of Medical Oncology, Department of Internal Medicine,Yonsei University College of MedicineDepartment of Internal Medicine,Seoul National University HospitalDepartment of Internal Medicine,Seoul St. Mary’s HospitalDepartment of Internal Medicine,Seoul National University Bundang HospitalDepartment of Oncology,Haeundae Paik HospitalDepartment of Internal Medicine,Pusan National University Yangsan HospitalDepartment of Internal Medicine,Chonnam National University Hwasun HospitalDepartment of Medical Oncology,CHA Bundang Medical Center;
atezolizumab; bevacizumab; hepatocellular carcinoma; neutrophil‐to‐lymphocyte ratio;